Is the “serious” factor in germline modification really relevant? A response to Kleiderman, Ravitsky and Knoppers

By Iñigo de Miguel Beriain Is the “serious” factor in germline modification relevant? This seems a relevant question in the germline gene editing debate. Of course, at first glance, one tends to choose an affirmative answer immediately. It seems common sense to think that sophisticated technology should be used only when we are faced with […]

Read More…

Why we should still accommodate conscientious objection for abortion

By Bruce P. Blackshaw and Daniel Rodger. Over the last few years there has been a vigorous and fascinating debate about the use of conscientious objection (CO) in healthcare. CO is when doctors (and other healthcare professionals) opt-out of providing a medical service because they have serious moral objections—abortion is a widely cited example. If […]

Read More…

‘Was this on the consent form?’ Can you really consent in a one-off conversation to interventions with uncertain and evolving consequences?

By Rachel Horton, Benjamin Bell, Angela Fenwick, Anneke Lucassen A child conceived with a donated egg has multiple health problems but no unifying diagnosis. Given that testing of biological parents may help make a genetic diagnosis in a child, is it OK to contact the child’s anonymous egg donor to ask if they would provide […]

Read More…

Reimagining Uterus Transplantation

By Amani Sampson, Laura Kimberly, Kara Goldman, David Keefe, and Gwendolyn Quinn. In 1931, a transgender woman named Lili Elbe received the first known uterus transplant in a human. Unfortunately, she died from organ rejection complications three months later. Her story is often missing from the emerging ethical discourse surrounding uterus transplantation. Our interest in exploring how uterus […]

Read More…

Rogue scientist: the human CRISPR experiment

By Jeanne Snelling and Mike King Chinese researcher, He Jiankui, claims to have implanted CRISPR-cas9 gene-edited embryos into potentially six women resulting in at least one successful pregnancy (of twins). Given the unconventional and inadequate way information has been released by He, and the fact that the research has not had thorough oversight, the facts […]

Read More…

Claims over human genome editing: scientific irresponsibility at its worst

By Sarah Chan This post first appeared in The Motley Coat on 26 November 2018. The announcement made today, that the world’s first genome-edited babies have been born in China, is of grave ethical concern. In evaluating this news, we should first remember that these claims have not yet been scientifically validated through peer reviewed publication […]

Read More…